Caris Life SciencesCAI
那斯達克 · USD
18.59
-0.63
(-3.28%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)
Caris Life SciencesCAI
18.59
-0.63
(-3.28%)
財務數據
損益表
- 0.82
- 0.81
- 0.86
- 1.01
- 0.81
- 1.00
- 1.21
- 1.81
- 2.17
- 2.93
- -10.50
- -0.94
- 6.06
- 17.66
- -
- 24.01
- -
- 50.02
- 19.53
- 35.07
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q2 | 2024/Q1 | 2021/Q3 | 2021/Q2 | 2021/Q1 | 2020/Q4 | |
營業收入淨額 | 292,886 | 216,833 | 181,399 | 120,915 | 100,049 | 80,677 | 100,827 | 85,695 | 80,800 | 81,567 |
營業成本 | 71,972 | 69,328 | 67,713 | 63,852 | 62,495 | 54,563 | - | - | - | - |
營業毛利 | 220,914 | 147,505 | 113,686 | 57,063 | 37,554 | 26,114 | 100,827 | 85,695 | 80,800 | 81,567 |
營業費用 | 132,503 | 114,863 | 131,675 | 115,014 | 104,565 | 118,339 | 47,576 | 41,882 | 38,780 | 39,226 |
研發費用 | 31,845 | 21,625 | 25,048 | 23,066 | 24,787 | 34,376 | - | - | - | - |
推銷及管理費用 | 100,658 | 93,238 | 106,627 | 91,948 | 79,778 | 83,963 | 14,898 | 12,612 | 10,229 | 11,435 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | 32,678 | 29,270 | 28,551 | 27,791 |
營業利益 | 88,411 | 32,642 | -17,988 | -57,952 | -67,011 | -92,225 | 66,443 | 50,839 | 48,763 | 46,691 |
其他收入及費用 | 4,902 | 5,190 | -34,593 | -31,847 | - | - | 13,040 | 7,100 | 6,333 | 2,547 |
利息費用 | 11,356 | 13,507 | 19,208 | 12,782 | 13,674 | 9,290 | 11,458 | 11,114 | 11,172 | 12,169 |
稅前純益 | 81,957 | 24,325 | -71,789 | -102,581 | -66,186 | -111,028 | 54,833 | 39,799 | 37,181 | 32,719 |
所得稅 | - | - | - | - | 0 | 0 | 3,678 | 1,856 | 2,504 | -2,000 |
稅後純益 | 81,957 | 24,325 | -71,789 | -102,581 | -66,186 | -111,028 | 51,155 | 37,943 | 35,740 | 14,246 |
基本每股稅後盈餘(元) | 5.06 | 0.09 | -7.97 | -0.40 | -0.35 | -0.53 | 2.82 | 2.07 | 1.94 | 0.68 |
稀釋每股稅後盈餘(元) | 1.61 | 7.97 | -9.23 | -3.57 | -0.35 | -0.53 | 2.79 | 2.05 | 1.91 | 0.67 |
基本平均股數(千股) | 67017.00 | 282099.00 | 64918.00 | 254788.00 | 254788.00 | 254788.00 | 17337.00 | 17281.00 | 17271.00 | 17711.00 |
稀釋平均股數(千股) | 51905.00 | 297211.00 | 64918.00 | 254788.00 | 254788.00 | 254788.00 | 17531.00 | 17479.00 | 17518.00 | 17949.00 |
還原基本每股稅後盈餘(元) | 5.06 | 0.09 | -7.97 | -0.40 | -0.35 | -0.53 | 2.82 | 2.07 | 1.94 | 0.68 |
還原稀釋每股稅後盈餘(元) | 1.61 | 7.97 | -9.23 | -3.57 | -0.35 | -0.53 | 2.79 | 2.05 | 1.91 | 0.67 |
還原基本平均股數(千股) | 67,017 | 282,099 | 64,918 | 254,788 | 254,788 | 254,788 | 17,337 | 17,281 | 17,271 | 17,711 |
還原稀釋平均股數(千股) | 51,905 | 297,211 | 64,918 | 254,788 | 254,788 | 254,788 | 17,531 | 17,479 | 17,518 | 17,949 |
EBITDA(千元) | 98,209 | 45,165 | -38,417 | -80,809 | -40,902 | -84,033 | 99,997 | 81,191 | 78,997 | 55,511 |